These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6123888)

  • 1. Will amitriptyline prevent the "cheese" reaction of monoamine-oxidase inhibitors?
    Pare CM; Kline N; Hallstrom C; Cooper TB
    Lancet; 1982 Jul; 2(8291):183-6. PubMed ID: 6123888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyramine studies and the safety of MAOI drugs.
    Simpson GM; White K
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):59-61. PubMed ID: 6735997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake.
    Salter M; Kenney A
    Cardiovasc Toxicol; 2018 Dec; 18(6):583-586. PubMed ID: 30083815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacological developments in antidepressants.
    Pare CM
    Psychopathology; 1986; 19 Suppl 2():103-7. PubMed ID: 3554297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amitriptyline protects patients on MAOIs from tyramine reactions.
    Kline NS; Pare M; Hallstrom C; Cooper TB
    J Clin Psychopharmacol; 1982 Dec; 2(6):434-5. PubMed ID: 7174870
    [No Abstract]   [Full Text] [Related]  

  • 7. The monoamine oxidase inhibitor-tyramine interaction.
    Brown C; Taniguchi G; Yip K
    J Clin Pharmacol; 1989 Jun; 29(6):529-32. PubMed ID: 2666453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amitriptyline and the "cheese" reaction to MAOIs.
    Spencer PS
    Lancet; 1982 Aug; 2(8294):385. PubMed ID: 6124785
    [No Abstract]   [Full Text] [Related]  

  • 9. Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients.
    Korn A; Eichler HG; Fischbach R; Gasic S
    Psychopharmacology (Berl); 1986; 88(2):153-7. PubMed ID: 3081926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient compliance with MAO inhibitor therapy.
    Walker JI; Davidson J; Zung WW
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibitor efficacy in depression and the "cheese effect".
    Sandler M
    Psychol Med; 1981 Aug; 11(3):455-8. PubMed ID: 6791195
    [No Abstract]   [Full Text] [Related]  

  • 12. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paroxystic hypertension after ingestion of gruyere cheese during isoniazide treatment: a report on two cases (author's transl)].
    Lejonc JL; Schaeffer A; Brochard P; Portos JL
    Ann Med Interne (Paris); 1980; 131(6):346-8. PubMed ID: 7469238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF
    Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant use of monoamine oxidase inhibitor and tyrosine in parenteral nutrition.
    Bharani T; Mogensen KM; Rosen JH; Gura KM; Robinson MK
    Eur J Clin Nutr; 2024 Mar; 78(3):274-276. PubMed ID: 38057413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoamine oxidase inhibition and hypertensive paroxysms: importance of the method of administration].
    Sicuteri F; Del Bianco PL; Del Bene E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(17):1163-6. PubMed ID: 5971368
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease.
    Youdim MB; Riederer PF
    Neurology; 2004 Oct; 63(7 Suppl 2):S32-5. PubMed ID: 15477584
    [No Abstract]   [Full Text] [Related]  

  • 19. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
    Evans L; George T; O'Sullivan B; Mitchell P; Johnson G; Adena M
    Aust N Z J Psychiatry; 1992 Sep; 26(3):454-8. PubMed ID: 1417632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction.
    Youdim MB
    Acta Psychiatr Scand Suppl; 1995; 386():5-7. PubMed ID: 7717095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.